TP53 and neoplasm: Based on this finding, Park et al. demonstrated that MDM2 and CK1α, in complex with MDM4, promote p53 degradation in MCCP cells while MDM2 and MDM4 inhibitors stabilized p53 and promoted p53-mediated tumor cell death [114].